Ameriprise Financial Inc Cytom X Therapeutics, Inc. Transaction History

Ameriprise Financial Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$1.23 - $1.97 $92,069 - $147,460	74,853 New	74,853 $109,000
Q3 2018 Nov 14, 2018	SELL	$18.04 - $26.41 $935,410 - $1.37 Million	-51,852 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$21.38 - $29.68 $20,118 - $27,928	-941 Reduced 1.78%	51,852 $1.19 Million
Q1 2018 May 15, 2018	BUY	$21.76 - $34.22 $1.15 Million - $1.81 Million	52,793 New	52,793 $1.5 Million

50.4M

112K

8.3K

Ticker CTMX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,950,200
Market Cap $66M
Description
CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical...

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Ameriprise Financial Inc with notifications on news.